# Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

> **NCT05065177** · PHASE3 · COMPLETED · sponsor: **Sinovac Research and Development Co., Ltd.** · enrollment: 1140 (actual)

## Conditions studied

- Mumps

## Interventions

- **BIOLOGICAL:** Investigational live attenuated mumps vaccine
- **BIOLOGICAL:** control live attenuated mumps vaccine

## Key facts

- **NCT ID:** NCT05065177
- **Lead sponsor:** Sinovac Research and Development Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-04
- **Target enrollment:** 1140 (ACTUAL)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065177, "Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05065177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*